[Apply the Miettinen Formula to Assess the Health Benefits of the PM<sub>2.5</sub> Simulation Intervention on Metabolic Syndrome]. [PDF]
Chen K, Han X, Yang Y, Wang P.
europepmc +1 more source
[Maximum limb reconstruction: concept and implementation strategies]. [PDF]
Zhu Y.
europepmc +1 more source
[Application of modified latissimus dorsi musculocutaneous flap in repair of Gustilo-Anderson type <b>Ⅲ</b>B and <b>Ⅲ</b> C upper limb injuries with composite tissue defects]. [PDF]
Liu H +7 more
europepmc +1 more source
[CRISPR-Cas9 activation screening identifies candidate chemokine regulators of ter-tiary lymphoid structure formation in bladder cancer]. [PDF]
Wang Y, Song H, DU Y, Xu T.
europepmc +1 more source
[Research progress of microfluidic technology in competitive sports]. [PDF]
Hu C, Zhang C, Fan Z, Deng X, Liu M.
europepmc +1 more source
[Occurrence characteristics, neurotoxicity risk, and potential mechanisms of traditional phthalate esters and novel alternatives in indoor dust]. [PDF]
Li W, Gao K, Hua K, Wang L, Wei W, Lu L.
europepmc +1 more source
[Research advances in non-pharmacological interventions in pediatric asthma]. [PDF]
Wang WR, Peng W, Zheng XR.
europepmc +1 more source
[Determination of 31 perfluoroalkyl and polyfluoroalkyl substances in water by ultra performance liquid chromatography-triple quadrupole mass spectrometry combined with direct injection]. [PDF]
Yang C +6 more
europepmc +1 more source
[<i>Wuzi Yanzong</i> Pill ameliorates diminished ovarian reserve in mice by inhibiting granulosa cell apoptosis <i>via</i> the TGF-β1/PI3K/Akt/mTOR pathway]. [PDF]
Liang Y +7 more
europepmc +1 more source

